Page last updated: 2024-08-23

2,2',4,4',5-pentachlorodiphenyl ether and scopolamine hydrobromide

2,2',4,4',5-pentachlorodiphenyl ether has been researched along with scopolamine hydrobromide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Farghaly, HSM; Gomaa, AA; Hussien, AM; Makboul, RM; Nicola, MA1

Other Studies

1 other study(ies) available for 2,2',4,4',5-pentachlorodiphenyl ether and scopolamine hydrobromide

ArticleYear
Polyphenols from Conyza dioscoridis (L.) ameliorate Alzheimer's disease- like alterations through multi-targeting activities in two animal models.
    BMC complementary medicine and therapies, 2022, Nov-08, Volume: 22, Issue:1

    Topics: Alzheimer Disease; Animals; Asteraceae; Conyza; Diabetes Mellitus, Type 2; Glycogen Synthase Kinase 3 beta; Models, Animal; Polyphenols; Rats; Rats, Wistar; Scopolamine

2022